[Breaking] C&G Hi-Tech Signs 20.3 Billion Won Semiconductor Manufacturing Equipment Supply Contract with Samsung Electronics, Nearing 10% of Annual Revenue
C&G Hi-Tech announced on the 29th that it has signed a 20.3748 billion won semiconductor manufacturing equipment supply contract with Samsung Electronics. The c
![[Breaking] C&G Hi-Tech Signs 20.3 Billion Won Semiconductor Manufacturing Equipment Supply Contract with Samsung Electronics, Nearing 10% of Annual Revenue](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581911/a630da1c47d6049c/variants/hero.webp)
C&G Hi-Tech announced on the 29th that it has signed a 20.3748 billion won semiconductor manufacturing equipment supply contract with Samsung Electronics.
The contract amount is 20.3748 billion won, excluding value-added tax. This figure accounts for 10.39% of C&G Hi-Tech's consolidated revenue for 2025 (19.619433 billion won).
The key contract details are as follows: • Counterparty: Samsung Electronics Co., Ltd. • Supply item: Semiconductor manufacturing equipment • Supply region: Domestic • Contract period: June 27, 2026 – November 30, 2026 (however, the end date may be changed by mutual agreement between the two parties)
Payment will be made with an interim payment of 90% and a final payment of 10%, with no separate down payment or advance payment. The equipment will be manufactured through a combination of in-house and outsourced production.
The company explained that the contract date stated in this disclosure is June 27, 2026, which is the date the Purchase Order was actually received.
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Sinsungdeltatech Surges 21% in Regular Session, Hits Upper Limit in NXT After-Hours](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/581031/0c2a8f5a6d5bef88/variants/hero.webp)
![[Breaking] Doosan Enerbility VI Triggered... Surges 9% After Two-Day Correction, Reclaiming 88,000 Won Level](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/580163/1396d4e6f2ae151a/variants/hero.webp)
![[Breaking News] Samsung Bioepis' Keytruda Biosimilar 'SB27' Demonstrates Equivalence in Global Phase 3 Trial](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/579545/36de0fb87055dd02/variants/hero.webp)
